Cargando…
Eriodictyol suppresses the malignant progression of colorectal cancer by downregulating tissue specific transplantation antigen P35B (TSTA3) expression to restrain fucosylation
Eriodictyol is a natural flavonoid with many pharmacological effects, such as anti-oxidation, anti-inflammation, anti-tumor, and neuroprotection. Besides, it has been reported that flavonoids play an important role in protein glycosylation. The fucosylation structure is closely associated with proce...
Autores principales: | Huang, Hua, He, Yun, Li, Youran, Gu, Mingjia, Wu, Minna, Ji, Lijiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973719/ https://www.ncbi.nlm.nih.gov/pubmed/35184647 http://dx.doi.org/10.1080/21655979.2022.2039485 |
Ejemplares similares
-
TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2
por: Zhang, Ling, et al.
Publicado: (2020) -
TSTA3 overexpression promotes malignant characteristics in LUSC by regulating LAMP2-mediated autophagy and tumor microenvironment
por: Guo, Yanlin, et al.
Publicado: (2023) -
Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2
por: Cheng, Fang-Ju, et al.
Publicado: (2023) -
High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients
With ESCC
por: Yang, Jie, et al.
Publicado: (2018) -
Downregulation of MCM8 expression restrains the malignant progression of cholangiocarcinoma
por: Hao, Jingcheng, et al.
Publicado: (2021)